Glickman R M, Kirsch K
J Clin Invest. 1973 Nov;52(11):2910-20. doi: 10.1172/JCI107487.
The effect of impaired intestinal protein synthesis on chylomicron apoprotein composition was studied in mesenteric lymph fistula rats. Lymph was obtained from animals with impaired protein synthesis given intraperitoneal acetoxycycloheximide (ACH), a potent inhibitor of protein synthesis. Lymph chylomicrons were then isolated by ultracentrifugation and purified on agarose columns. Purified chylomicrons from control and ACH-treated animals were delipidated, and their apoprotein pattern was examined on sodium dodecyl sulfate (SDS) polyacrylamide gels. Because we had previously demonstrated a markedly increased lymph chylomicron size during the inhibition of protein synthesis, it was first necessary to determine whether chylomicron apoprotein composition normally varied with chylomicron size. Chylomicrons of varying sizes were prepared by differential ultracentrifugation, and their apoprotein composition was determined densitometrically on SDS polyacrylamide gels. No significant difference in apoprotein composition was found normally with varying chylomicron size. In contrast, however, chylomicrons from ACH-treated animals showed a 50% decrease in a major apoprotein band with R(1) 0.67. Other chylomicron apoproteins were not decreased as a result of impaired protein synthesis, suggesting differing rates of synthesis of the various chylomicron apoproteins. In vivo incorporation studies of [(3)H]leucine into the various apoproteins of lymph chylomicrons demonstrated that this apoprotein (R(1) 0.67) had the most rapid synthesis rate and suggested that it seemed most affected by impaired intestinal protein synthesis. Immunologic studies indicated that this apoprotein was immunologically related to high-density lipoproteins (HDL) and was present in chylomicrons isolated directly from small intestinal mucosa. These studies demonstrate that impaired intestimal protein synthesis is associated with a deficiency in one of the major chylomicron apoproteins and may in part explain the impaired lipid absorption seen during states of impaired protein synthesis.
在肠系膜淋巴瘘大鼠中研究了肠道蛋白质合成受损对乳糜微粒载脂蛋白组成的影响。从给予腹腔注射乙酰氧基环己酰亚胺(ACH,一种有效的蛋白质合成抑制剂)从而导致蛋白质合成受损的动物身上获取淋巴液。然后通过超速离心分离淋巴乳糜微粒,并在琼脂糖柱上进行纯化。将来自对照动物和经ACH处理动物的纯化乳糜微粒脱脂,并在十二烷基硫酸钠(SDS)聚丙烯酰胺凝胶上检查其载脂蛋白模式。由于我们之前已经证明在蛋白质合成受抑制期间淋巴乳糜微粒大小显著增加,因此首先有必要确定乳糜微粒载脂蛋白组成是否通常随乳糜微粒大小而变化。通过差速超速离心制备不同大小的乳糜微粒,并在SDS聚丙烯酰胺凝胶上通过光密度法测定其载脂蛋白组成。正常情况下,不同大小的乳糜微粒在载脂蛋白组成上未发现显著差异。然而,相比之下,来自经ACH处理动物的乳糜微粒在Rf为0.67的一条主要载脂蛋白带中显示减少了50%。其他乳糜微粒载脂蛋白并未因蛋白质合成受损而减少,这表明各种乳糜微粒载脂蛋白的合成速率不同。对淋巴乳糜微粒的各种载脂蛋白进行体内[³H]亮氨酸掺入研究表明,这种载脂蛋白(Rf 0.67)具有最快的合成速率,并表明它似乎受肠道蛋白质合成受损的影响最大。免疫学研究表明,这种载脂蛋白与高密度脂蛋白(HDL)在免疫学上相关,并且存在于直接从小肠黏膜分离的乳糜微粒中。这些研究表明,肠道蛋白质合成受损与一种主要乳糜微粒载脂蛋白的缺乏有关,并且可能部分解释了在蛋白质合成受损状态下所见的脂质吸收受损情况。